GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (HKSE:03933) » Definitions » PS Ratio

United Laboratories International Holdings (HKSE:03933) PS Ratio : 1.09 (As of May. 26, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, United Laboratories International Holdings's share price is HK$9.04. United Laboratories International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$8.27. Hence, United Laboratories International Holdings's PS Ratio for today is 1.09.

The historical rank and industry rank for United Laboratories International Holdings's PS Ratio or its related term are showing as below:

HKSE:03933' s PS Ratio Range Over the Past 10 Years
Min: 0.51   Med: 0.97   Max: 1.88
Current: 1.09

During the past 13 years, United Laboratories International Holdings's highest PS Ratio was 1.88. The lowest was 0.51. And the median was 0.97.

HKSE:03933's PS Ratio is ranked better than
70.57% of 999 companies
in the Drug Manufacturers industry
Industry Median: 2.16 vs HKSE:03933: 1.09

United Laboratories International Holdings's Revenue per Sharefor the six months ended in Dec. 2023 was HK$4.11. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$8.27.

During the past 12 months, the average Revenue per Share Growth Rate of United Laboratories International Holdings was 18.90% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 10.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 5.50% per year.

During the past 13 years, United Laboratories International Holdings's highest 3-Year average Revenue per Share Growth Rate was 29.10% per year. The lowest was -3.70% per year. And the median was 6.90% per year.

Back to Basics: PS Ratio


United Laboratories International Holdings PS Ratio Historical Data

The historical data trend for United Laboratories International Holdings's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings PS Ratio Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.94 0.68 0.70 0.85

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.68 - 0.70 - 0.85

Competitive Comparison of United Laboratories International Holdings's PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's PS Ratio falls into.



United Laboratories International Holdings PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

United Laboratories International Holdings's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=9.04/8.27
=1.09

United Laboratories International Holdings's Share Price of today is HK$9.04.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. United Laboratories International Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$8.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


United Laboratories International Holdings  (HKSE:03933) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


United Laboratories International Holdings PS Ratio Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (HKSE:03933) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.
Executives
Heren Far East #4 Limited 2201 Interest of corporation controlled by you
Heren Far East Limited 2101 Beneficial owner
Iq Eq Services (hk) Limited 2201 Interest of corporation controlled by you

United Laboratories International Holdings (HKSE:03933) Headlines

No Headlines